LivaNova Plc (LIVN)
79.61
+0.14
(+0.18%)
USD |
NASDAQ |
Sep 16, 12:40
LivaNova Enterprise Value : 4.210B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 4.210B |
| September 14, 2026 | 4.274B |
| September 11, 2026 | 4.139B |
| September 10, 2026 | 4.139B |
| September 09, 2026 | 4.181B |
| September 08, 2026 | 4.278B |
| September 04, 2026 | 4.345B |
| September 03, 2026 | 4.306B |
| September 02, 2026 | 4.372B |
| September 01, 2026 | 4.248B |
| August 31, 2026 | 4.229B |
| August 28, 2026 | 4.257B |
| August 27, 2026 | 4.241B |
| August 26, 2026 | 4.238B |
| August 25, 2026 | 4.207B |
| August 24, 2026 | 4.144B |
| August 21, 2026 | 4.170B |
| August 20, 2026 | 4.141B |
| August 19, 2026 | 4.286B |
| August 18, 2026 | 4.232B |
| August 17, 2026 | 4.321B |
| August 14, 2026 | 4.362B |
| August 13, 2026 | 4.361B |
| August 12, 2026 | 4.282B |
| August 11, 2026 | 4.161B |
| Date | Value |
|---|---|
| August 10, 2026 | 4.046B |
| August 07, 2026 | 4.031B |
| August 06, 2026 | 4.007B |
| August 05, 2026 | 4.137B |
| August 04, 2026 | 4.533B |
| August 03, 2026 | 4.375B |
| July 31, 2026 | 4.247B |
| July 30, 2026 | 4.297B |
| July 29, 2026 | 4.318B |
| July 28, 2026 | 4.355B |
| July 27, 2026 | 4.271B |
| July 24, 2026 | 4.140B |
| July 23, 2026 | 4.163B |
| July 22, 2026 | 4.144B |
| July 21, 2026 | 4.231B |
| July 20, 2026 | 4.196B |
| July 17, 2026 | 4.278B |
| July 16, 2026 | 4.338B |
| July 15, 2026 | 4.207B |
| July 14, 2026 | 4.191B |
| July 13, 2026 | 4.404B |
| July 10, 2026 | 4.380B |
| July 09, 2026 | 4.378B |
| July 08, 2026 | 4.378B |
| July 07, 2026 | 4.437B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| NovoCure Ltd. | 1.663B |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
| Polarean Imaging Plc | -- |
| Medtronic Plc | 139.96B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 108.57M |
| Revenue (Quarterly) | 390.59M |
| Total Expenses (Quarterly) | 282.02M |
| EPS Diluted (Quarterly) | 1.929 |
| Gross Profit Margin (Quarterly) | 70.32% |
| Profit Margin (Quarterly) | 27.80% |
| Earnings Yield | 4.23% |
| Operating Earnings Yield | 4.98% |
| Normalized Earnings Yield | 6.342 |